Your browser does not support iframes.
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Abbott Laboratories
(NY:
ABT
)
37.48
USD
-0.24 (-0.64%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 23, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Abbott Laboratories
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
99
100
Next >
Intuitive Surgical’s Strong Sales And Growing Procedures Lifts Outlook
January 23, 2013
category
Pharmaceuticals
,
Medical Devices & Supplies
from
Trefis
Earnings Scheduled For January 23, 2013
January 23, 2013
Abbott Laboratories (NYSE: ABT ) is expected to report its Q4 earnings at $1.50 per share on revenue of $10.58 billion. Apple (NASDAQ: AAPL ) is estimated to post its Q1 earnings at $13.42 per share on...
Read More
category
MSI
,
Earnings
,
SYK
, and 51 more.
from
Latest Articles from Benzinga.com
Trading Radar for 01/23: Apple (AAPL), Netflix (NFLX), McDonalds (MCD), Sandisk (SNDK), Western Digital (WDC) Report
January 22, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8022837 for the full story.
Read More
from
StreetInsider.com News Articles
Next Resistance Level for Abbott Laboratories (ABT) is $33.00
January 22, 2013
from
Comtex SmarTrend® News Briefs
Abbott Earnings Preview: What We Are Watching
January 22, 2013
Abbott Labs is set to announce its Q4 results on January 23. It will be diversified healthcare company’s last quarterly and annual earnings, which will include the performance of research-based...
Read More
category
NYSE:ABT
from
Forbes Real Time
Weekly Healthcare Notes: Roche Holdings, Pfizer & JNJ
January 21, 2013
category
Pharmaceuticals
,
Medical Devices & Supplies
from
Trefis
Intuitive Surgical Earnings Preview: What We Are Watching
January 21, 2013
category
Pharmaceuticals
,
Medical Devices & Supplies
from
Trefis
Will Tech Earnings Charge Up the Stock Market Rally?
January 18, 2013
A flood of earnings reports, including major technology and industrial companies, could make or break the stock market's surprise January rally in the week ahead.
Read More
category
Life and Leisure/Housing
,
Economics/Economic Measures
,
Lam Research Corporation
, and 104 more.
from
CNBC.com News
Abbott Earnings Preview: What We Are Watching
January 18, 2013
category
Pharmaceuticals
,
Medical Devices & Supplies
from
Trefis
JNJ Q4 Earnings Preview: Pharma Business And Synthes Impact In Focus
January 18, 2013
category
Pharmaceuticals
from
Trefis
Anything For A Buck: Jim Letourneau Looks To Canadian Biotech for Opportunity
January 18, 2013
category
Pharmaceuticals
from
Trefis
Why Dr. Oz’s Endorsement Of ChromaDex’s Product Is Huge
January 18, 2013
category
Pharmaceuticals
from
Trefis
Pfizer Could Get Boost With New Breast Cancer Drug
January 17, 2013
category
Pharmaceuticals
from
Trefis
Cramer: After Abbott Labs Spin-Off, Own ABT or AbbVie?
January 15, 2013
Now that Abbot Labs has spun-off part of its business into a new company called AbbVie, which is the better stock to own?
Read More
category
Abbott Laboratories
,
Mad Money for Mobile
,
Investing/Investment Strategy
, and 5 more.
from
CNBC.com News
Noteworthy ETF Outflows: OEF, CVS, LLY, ABT
January 15, 2013
Symbols mentioned in this story: OEF, CVS, LLY, ABT Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Read More
category
ETFs
from
ETF Channel
EmergingGrowth.com Reports on Orexigen, Behind the Recent Surge
January 15, 2013
category
AGRICULTURE
,
NUTRITION
,
RELIGION
, and 128 more.
from
Latest eTeligis Press Releases with 'Plus' ranking
JNJ Gains Momentum With Approvals For Broader Use Of Zytiga
January 14, 2013
category
Pharmaceuticals
from
Trefis
3 Sectors to Avoid this Earnings Season
January 14, 2013
Read More
category
NYSE:TRV
,
NYSE:PFE
,
NYSE:ABT
, and 3 more.
from
InvestorPlace - Latest Headlines
Notable Analyst Rating Changes 01/11: (MTH) (NOK) (F) Upgraded; (ZQK) (GIS) (JCP) Downgraded
January 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8002856 for the full story.
Read More
from
StreetInsider.com News Articles
Weekly Healthcare Notes: Pfizer, Abbott Labs, Merck & JNJ
January 11, 2013
category
Pharmaceuticals
from
Trefis
New Stock Coverage: Good Things on Tap at Molson Coors
January 11, 2013
There were high fives all around in equities with the S&P 500 Index (^GSPC) hitting a five-year high as continuing unemployment claims fell to a five-year low notwithstanding that the initial jobless...
Read More
from
Minyanville Headlines
Merck, Abbott And JNJ Show Interest In Bausch & Lomb
January 11, 2013
category
Pharmaceuticals
from
Trefis
Barclays Starts Abbott Labs (ABT) at Equalweight
January 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8002279 for the full story.
Read More
from
StreetInsider.com News Articles
Next Resistance Level for Abbott Laboratories (ABT) is $34.08
January 10, 2013
from
Comtex SmarTrend® News Briefs
Cash Dividend On The Way From Abbott Laboratories (ABT)
January 09, 2013
On 1/11/13, Abbott Laboratories (ABT) will trade ex-dividend, for its quarterly dividend of $0.14, payable on 2/15/13. As a percentage of ABT's recent stock price of $33.14, this dividend works out to...
Read More
category
Dividends
from
Dividend Channel
Pfizer Updates: Europe Approves Expanded Use Of Prevenar 13
January 09, 2013
category
Pharmaceuticals
from
Trefis
AbbVie sees no need for major acquisitions-CFO
January 09, 2013
SAN FRANCISCO, Jan 8 (Reuters) - AbbVie Inc, the pharmaceutical company spun off by Abbott Laboratories, is unlikely to use its $7 billion cash balance for a large acquisition, the company's chief...
Read More
category
companyNews
from
Reuters: Company News
Ryan: Is the Health Care Sector 'Healthy?'
January 07, 2013
A record crowd of healthcare investors and companies gather this week in San Francisco for the Annual JPMorgan Healthcare Conference - here's what you need to know about sector.
Read More
category
Aetna Inc
,
ONYX Pharmaceuticals Inc
,
Merck & Co Inc
, and 17 more.
from
CNBC.com News
After Johnson & Johnson’s Eventful 2012, What Will 2013 Bring?
January 07, 2013
category
Pharmaceuticals
,
Medical Devices & Supplies
from
Trefis
Which Abbott Shares Should You Keep?
January 07, 2013
And then there were two. On January 1 Abbott Laboratories (NYSE:ABT) split into two companies with two different stocks. AbbVie (NYSE:ABBV) is the drug company that owns Humira a big selling...
Read More
from
Minyanville Headlines
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
99
100
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.